Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value: $180M (100.0% shares, 0.0% debt)

Holdings (34)

ZBH ZIMMER BIOMET HOLDINGS INC 9.7%
Value $17.57M Shares 128,000 Est. Cost $109.74 Unrealized +11.7%
BMY BRISTOL-MYERS SQUIBB CO 8.6%
Value $15.46M Shares 304,900 Est. Cost $37.62 Unrealized -2.3%
KURA KURA ONCOLOGY INC 7.5%
Value $13.47M Shares 888,152 Est. Cost $16.55 Unrealized +7.6%
QURE UNIQURE NV 7.2%
Value $12.95M Shares 328,978 Est. Cost $59.89 Unrealized -3.7%
UTHR UNITED THERAPEUTICS CORP 5.9%
Value $10.6M Shares 132,937 Est. Cost $81.37 Unrealized -1.0%
HANGER INC 4.5%
Value $8.05M Shares 395,000 Est. Cost $20.83 Unrealized
URGN UROGEN PHARMA LTD 4.3%
Value $7.754M Shares 325,385 Est. Cost $38.49 Unrealized -15.1%
ARENA PHARMACEUTICALS INC 4.1%
Value $7.467M Shares 163,133 Est. Cost $42.17 Unrealized
CNC CENTENE CORP 4.0%
Value $7.138M Shares 165,000 Est. Cost $55.81 Unrealized -12.7%
IOVA IOVANCE BIOTHERAPEUTICS INC 3.5%
Value $6.3M Shares 346,149 Est. Cost $11.58 Unrealized +90.9%
ACIU AC IMMUNE SA 3.4%
Value $6.18M Shares 1,248,453 Est. Cost $5.81 Unrealized -7.8%
BMRN BIOMARIN PHARMACEUTICAL INC 3.4%
Value $6.063M Shares 89,952 Est. Cost $85.35 Unrealized -9.8%
STRONGBRIDGE BIOPHARMA PLC 3.3%
Value $6.011M Shares 2,515,072 Est. Cost $3.69 Unrealized
MGTX MEIRAGTX HOLDINGS PLC 3.0%
Value $5.393M Shares 338,096 Est. Cost $23.27 Unrealized 0.0%
ALBIREO PHARMA INC 2.8%
Value $5.05M Shares 252,500 Est. Cost $29.61 Unrealized
REATA PHARMACEUTICALS INC-A 2.8%
Value $5.025M Shares 62,591 Est. Cost $46.26 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 2.3%
Value $4.165M Shares 790,228 Est. Cost $8.89 Unrealized -39.4%
R1 RCM INC 2.0%
Value $3.652M Shares 408,958 Est. Cost $8.93 Unrealized
HUM HUMANA INC 1.7%
Value $3.068M Shares 12,000 Est. Cost $265.05 Unrealized 0.0%
ABBV ABBVIE INC 1.6%
Value $2.953M Shares 39,000 Est. Cost $52.58 Unrealized 0.0%
HOMOLOGY MEDICINES INC 1.5%
Value $2.775M Shares 153,303 Est. Cost $19.57 Unrealized
CATALYST BIOSCIENCES INC 1.5%
Value $2.741M Shares 558,159 Est. Cost $9.00 Unrealized
GH GUARDANT HEALTH INC 1.5%
Value $2.662M Shares 41,700 Est. Cost $88.10 Unrealized 0.0%
ARQULE INC 1.5%
Value $2.616M Shares 364,797 Est. Cost $8.05 Unrealized
ADMA ADMA BIOLOGICS INC 1.4%
Value $2.44M Shares 548,409 Est. Cost $4.26 Unrealized -1.9%
TELIGENT INC 1.3%
Value $2.323M Shares 2,446,043 Est. Cost $3.21 Unrealized
CLOVIS ONCOLOGY INC 1.3%
Value $2.309M Shares 587,626 Est. Cost $15.83 Unrealized
PSNL PERSONALIS INC 0.9%
Value $1.691M Shares 115,214 Est. Cost $23.50 Unrealized -19.5%
CI CIGNA CORP 0.9%
Value $1.67M Shares 11,000 Est. Cost $179.63 Unrealized -17.1%
MOLECULAR TEMPLATES INC 0.8%
Value $1.47M Shares 222,994 Est. Cost $5.90 Unrealized
REATA PHARMACEUTICALS INC 0.5%
Value $988K Shares 12,300 Est. Cost Unrealized
UROV UROVANT SCIENCES LTD 0.5%
Value $972K Shares 102,657 Est. Cost $9.41 Unrealized
SIERRA ONCOLOGY INC 0.5%
Value $924K Shares 2,366,707 Est. Cost $1.83 Unrealized
MILLENDO THERAPEUTICS INC 0.2%
Value $370K Shares 52,051 Est. Cost $8.31 Unrealized